Gastrointestinal Diseases Stocks List for 2021 |

Gastrointestinal Diseases Related ETFs
Recent Technical Analysis Signals
Recent Gastrointestinal Diseases Stock News

Symbol	Grade	Name	% Change
ALBO	F	Albireo Pharma, Inc.	-0.63
IRWD	F	Ironwood Pharmaceuticals, Inc.	2.10
QDEL	F	Quidel Corporation	-1.14
VIVO	D	Meridian Bioscience Inc.	-2.90
KIN	D	Kindred Biosciences, Inc.	-1.74
CRHM	B	CRH Medical Corporation	-0.51
AZRX	C	AzurRx BioPharma, Inc.	-4.64
SNGX	F	Soligenix, Inc.	-1.79
PHAT	C	Phathom Pharmaceuticals, Inc.	-4.32

View As Page of Charts

Related ETFs - A few ETFs which own one or more of the above listed Gastrointestinal Diseases stocks.

Symbol	Grade	Name	Weight
GERM	B	ETFMG Treatments Testing and Advancements ETF	4.64
XHE	B	SPDR S&P Health Care Equipment	2.51
ACTV	B	LeaderShares Activist Leaders ETF	2.29
FTXH	C	First Trust Nasdaq Pharmaceuticals ETF	2.29
RFG	B	Guggenheim S&P Midcap 400 Pure Growth ETF	2.28

View all Gastrointestinal Diseases related ETFs...

Compare ETFs

Compare ACTV to FTXH

Compare GERM to ACTV

Compare XHE to FTXH

Recent Signals

Date	Stock	Signal	Type
2021-02-26	ALBO	Doji - Bullish?	Reversal
2021-02-26	CRHM	Narrow Range Bar	Range Contraction
2021-02-26	IRWD	Lower Bollinger Band Walk	Weakness
2021-02-26	IRWD	Pocket Pivot	Bullish Swing Setup
2021-02-26	KIN	New Downtrend	Bearish
2021-02-26	KIN	MACD Bearish Centerline Cross	Bearish
2021-02-26	PHAT	MACD Bearish Signal Line Cross	Bearish
2021-02-26	PHAT	20 DMA Support	Bullish
2021-02-26	QDEL	NR7	Range Contraction
2021-02-26	VIVO	MACD Bearish Centerline Cross	Bearish

Recent News for Gastrointestinal Diseases Stocks

Date	Stock	Title
Feb 26	ALBO	Albireo Spotlights Global Patient Communities on Rare Disease Day
Feb 26	ALBO	Albireo Pharma, Inc. (ALBO) Q4 2020 Earnings Call Transcript
Feb 26	CRHM	INVESTIGATION ALERT: Halper Sadeh LLP Investigates the Following Companies on Behalf of Shareholders - PAND, PRAH, AEGN, PTVCA, CRHM, CBLI, AKER
Feb 26	ALBO	Albireo Pharma, Inc. (ALBO) CEO Ron Cooper on Q4 2020 Results - Earnings Call Transcript
Feb 25	ALBO	Albireo Pharma, Inc. 2020 Q4 - Results - Earnings Call Presentation
Feb 25	KIN	Kindred Biosciences Submits Efficacy Data For KIND-030 As Prophylactic Option In US
Feb 25	KIN	Kindred submits efficacy data to support KIND-030 prophylactic indication approval
Feb 25	ALBO	Albireo Pharma EPS beats by $0.59, beats on revenue
Feb 25	KIN	Kindred Biosciences Announces Submission of Parvovirus Monoclonal Antibody Data for Prophylactic Indication
Feb 25	ALBO	Albireo Reports Q4 and Year-End 2020 Financial Results and Business Update
Feb 25	KIN	Is Kindred Biosciences (NASDAQ:KIN) Using Too Much Debt?
Feb 24	CRHM	CRH MEDICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of CRH Medical Corporation - CRHM
Feb 24	AZRX	AzurRx BioPharma Appoints President and CEO James Sapirstein as New Chairman of the Board of Directors
Feb 24	SNGX	Soligenix Provides Important Highlights and Upcoming Catalysts in Corporate Update Letter
Feb 23	VIVO	Cannabis Stock Gainers And Losers From February 23, 2021
Feb 23	VIVO	SHAREHOLDER ALERT: Meridian Bioscience, Inc. Investigated for Possible Securities Laws Violations by Block & Leviton LLP; Investors Should Contact the Firm
Feb 23	VIVO	Meridian Bioscience issues correction: It can't ship its Revogene SARS-CoV-2 test until EUA is granted
Feb 23	VIVO	Meridian Bioscience corrects prior update on Revogene sars-cov-2 EUA withdrawal
Feb 23	VIVO	Meridian Bioscience Corrects Prior Update Regarding Revogene® SARS-CoV-2 EUA Withdrawal
Feb 23	VIVO	Meridian Bioscience Pulls Out Revogene COVID-19 Test EUA Application

Browse All Tags